Given the driver role of the neutralizing anti-GM-CSF antibody in the pathogenesis of aPAP, we finally sought to investigate the association of the risk HLA alleles with serum anti-GM-CSF antibody levels. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.